Baidu
map

2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防

2018-03-02 欧洲艰难梭菌研究小组 Clin Microbiol Infect. 2018 Mar 2.

2018年3月,欧洲艰难梭菌研究小组(ESGCD)发布了急诊医疗中艰难梭菌感染的预防指南,艰难梭菌感染是发达国家腹泻的重要感染因素,本文主要针对成人在急诊医疗中艰难梭菌感染的预防提出指导建议,内容包括艰难梭菌感染的诊断和预防,监测,无症状患者筛查,手卫生,个人防护等。

中文标题:

2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防

英文标题:

Guidance document for prevention of Clostridium difficile infection in acute healthcare settings

发布日期:

2018-03-02

简要介绍:

2018年3月,欧洲艰难梭菌研究小组(ESGCD)发布了急诊医疗中艰难梭菌感染的预防指南,艰难梭菌感染是发达国家腹泻的重要感染因素,本文主要针对成人在急诊医疗中艰难梭菌感染的预防提出指导建议,内容包括艰难梭菌感染的诊断和预防,监测,无症状患者筛查,手卫生,个人防护等。

 

拓展指南:急诊相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防)] GetToolGuiderByIdResponse(projectId=1, id=656511c001583af3, title=2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防, enTitle=Guidance document for prevention of Clostridium difficile infection in acute healthcare settings, guiderFrom=Clin Microbiol Infect. 2018 Mar 2., authorId=null, author=, summary=2018年3月,欧洲艰难梭菌研究小组(ESGCD)发布了急诊医疗中艰难梭菌感染的预防指南,艰难梭菌感染是发达国家腹泻的重要感染因素,本文主要针对成人在急诊医疗中艰难梭菌感染的预防提出指导建议,内容包括艰难梭菌感染的诊断和预防,监测,无症状患者筛查,手卫生,个人防护等。 , cover=, journalId=null, articlesId=null, associationId=1635, associationName=欧洲艰难梭菌研究小组, associationIntro=, copyright=0, guiderPublishedTime=Fri Mar 02 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年3月,欧洲艰难梭菌研究小组(ESGCD)发布了急诊医疗中艰难梭菌感染的预防指南,艰难梭菌感染是发达国家腹泻的重要感染因素,本文主要针对成人在急诊医疗中艰难梭菌感染的预防提出指导建议,内容包括艰难梭菌感染的诊断和预防,监测,无症状患者筛查,手卫生,个人防护等。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>急诊</FONT>相关指南:</STRONG><BR> <UL> <LI><A title=急诊氧气治疗专家共识 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=84cff1c0015e86dc">急诊氧气治疗专家共识</A> <LI><A title=中国急性缺血性脑卒中中西医急诊诊治专家共识 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=cd7ce1c0015e2945">中国急性缺血性脑卒中中西医急诊诊治专家共识</A> <LI><A title="2018 AAEM意见书:急诊科急性疼痛的治疗" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=3524d1c00156e31b">2018 AAEM意见书:急诊科急性疼痛的治疗</A> <LI><A title=眩晕急诊诊断与治疗专家共识 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=a82431c00156a521">眩晕急诊诊断与治疗专家共识</A> <LI><A title="2018 APAGE/APSDE实践指南:服用抗栓药物患者接受急诊和择期内镜检查的管理" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=5e0631c00155e2e9">2018 APAGE/APSDE实践指南:服用抗栓药物患者接受急诊和择期内镜检查的管理</A> 更多信息请点击:<A target=_blank href="//m.capotfarm.com/guideline/list.do?q=%E6%80%A5%E8%AF%8A">有关急诊更多指南</A></LI></UL>, tagList=[TagDto(tagId=24303, tagName=急诊医疗), TagDto(tagId=11318, tagName=艰难梭菌感染)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5631, appHits=152, showAppHits=0, pcHits=4164, showPcHits=1924, likes=134, shares=5, comments=4, approvalStatus=1, publishedTime=Tue Apr 24 22:18:39 CST 2018, publishedTimeString=2018-03-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 24 22:18:39 CST 2018, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 22:58:22 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防)])
2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=309984, encodeId=bca930998462, content=好文献学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 28 06:45:23 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309208, encodeId=0a7730920842, content=好文章.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Wed Apr 25 19:05:50 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309071, encodeId=64293090e1f3, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed Apr 25 07:30:29 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308964, encodeId=b37b3089640b, content=关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Tue Apr 24 23:04:08 CST 2018, time=2018-04-24, status=1, ipAttribution=)]
    2018-04-28 张新亮1853311252142e2fm

    好文献学习啦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=309984, encodeId=bca930998462, content=好文献学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 28 06:45:23 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309208, encodeId=0a7730920842, content=好文章.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Wed Apr 25 19:05:50 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309071, encodeId=64293090e1f3, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed Apr 25 07:30:29 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308964, encodeId=b37b3089640b, content=关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Tue Apr 24 23:04:08 CST 2018, time=2018-04-24, status=1, ipAttribution=)]
    2018-04-25 张新亮1853311252142e2fm

    好文章.学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=309984, encodeId=bca930998462, content=好文献学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 28 06:45:23 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309208, encodeId=0a7730920842, content=好文章.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Wed Apr 25 19:05:50 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309071, encodeId=64293090e1f3, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed Apr 25 07:30:29 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308964, encodeId=b37b3089640b, content=关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Tue Apr 24 23:04:08 CST 2018, time=2018-04-24, status=1, ipAttribution=)]
    2018-04-25 飛歌

    厉害了我的哥

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=309984, encodeId=bca930998462, content=好文献学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 28 06:45:23 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309208, encodeId=0a7730920842, content=好文章.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Wed Apr 25 19:05:50 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309071, encodeId=64293090e1f3, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed Apr 25 07:30:29 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308964, encodeId=b37b3089640b, content=关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Tue Apr 24 23:04:08 CST 2018, time=2018-04-24, status=1, ipAttribution=)]
    2018-04-24 紫迎馨

    关注

    0

Baidu
map
Baidu
map
Baidu
map